FEMALE | |
---|---|
Right | |
C50.811 | Malignant neoplasm of overlapping sites, right female breast |
C50.911 | Malignant neoplasm of unspecified site, right female breast |
D05.01 | Lobular carcinoma in situ, right breast |
Oct 01, 2021 · C50.911 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Malignant neoplasm of unsp site of right female breast. The 2022 edition of ICD-10-CM C50.911 became effective on October 1, …
C50.911 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of unspecified site of right female breast. The code C50.911 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions. The ICD-10-CM code C50.911 might also be used to specify conditions or terms …
| ICD-10 from 2011 - 2016 C50.911 is a billable ICD code used to specify a diagnosis of malignant neoplasm of unspecified site of right female breast. A 'billable code' is detailed enough to be used to specify a medical diagnosis. The ICD code C50 is used to code Urogenital neoplasm A urogenital neoplasm is a tumor of the urogenital system.
Oct 01, 2021 · C50.911. C50.911 is a valid billable ICD-10 diagnosis code for Malignant neoplasm of unspecified site of right female breast . It is found in the 2022 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2021 - …
ICD-10: | Z90.13 |
---|---|
Short Description: | Acquired absence of bilateral breasts and nipples |
Long Description: | Acquired absence of bilateral breasts and nipples |
C50.911 is a billable diagnosis code used to specify a medical diagnosis of malignant neoplasm of unspecified site of right female breast. The code C50.911 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.#N#The ICD-10-CM code C50.911 might also be used to specify conditions or terms like infiltrating duct carcinoma of bilateral female breasts, infiltrating duct carcinoma of left female breast, infiltrating duct carcinoma of right female breast, infiltrating duct carcinoma of right female breast, infiltrating lobular carcinoma of breast , infiltrating lobular carcinoma of right female breast, etc.#N#The code C50.911 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.#N#Unspecified diagnosis codes like C50.911 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Breast cancer affects one in eight women during their lives. No one knows why some women get breast cancer, but there are many risk factors. Risks that you cannot change include
Age - the risk rises as you get older. Genes - two genes, BRCA1 and BRCA2, greatly increase the risk. Women who have family members with breast or ovarian cancer may wish to be tested for the genes. Personal factors - beginning periods before age 12 or going through menopause after age 55.
Hormone therapy for breast cancer (Medical Encyclopedia) [ Learn More in MedlinePlus ] Breast cancer Breast cancer is a disease in which certain cells in the breast become abnormal and multiply uncontrollably to form a tumor.
Most men have little or no lobular tissue, so lobular cancer in men is very rare.In its early stages, breast cancer usually does not cause pain and may exhibit no noticeable symptoms.
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code C50.911 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
In both women and men, the most common form of breast cancer begins in cells lining the milk ducts (ductal cancer). In women, cancer can also develop in the glands that produce milk (lobular cancer).